Applying Patent for Non-Invasive Glucose Meter

Philosys, specialized in selling of blood glucose meter, have applied 2 different patents for Non-Invasive Meters which have allowed Philosys to position at a higher ground for future blood glucose market. As of 2014, diabetic patients in Korea record at 2,500,000 and are increasing rapidly every year with type 1 diabetes at a steady increase.[…]

Applying Patent for Insulin Pen

Philosys, specialized in selling of blood glucose meter, have applied 3 different patents for insulin pen. This allowed Philosys to gain exclusive competitiveness for digital insulin pen. In 2015, diabetic patients were over 400,000,000 worldwide with prevalence of 7% which rapidly adds to the patient population. In Korea, due to the prevalence of western diet[…]

Philosys will Participate in CMEF 2016

Philosys will participate in CMEF 2016 held in Shanghai international convention center from April 17th to April 20th. We are going to introduce Gmate Smart and Gmate Step which has necessary certifications including FDA, CE and China’s CFDA. CMEF is one of China’s largest medical device exhibitions suitable for domestic and foreign companies eager to[…]

Philosys will Participate in Arab Health 2016

Warm wishes for a prosperous and happy new year! Worldwide healthcare exhibition, Arab Health 2016 held in Dubai International Convention & Exhibition Centre on January 25-28 is drawing near. Philosys presents Gmate Smart and Gmate Voice during this exhibition Philosys welcomes you to visit booth, Z5A01 at Za’abeel Hall 5. For prior arrangements or questions,[…]

Philosys at 51th EASD

Philosys at 51th EASD(European Association for the Study of Diabetes) 2015 Philosys will participate in EASD 2015 held in Stockholm exhibition, Sweden from Sep, 14th to 18th. Maximum 18,000 people from more than 100 countries around the world will participate 51th EASD 2015. Philosys’s booth number is B14:38 and we will show the new blood[…]

Renewal of Philosys’ facebook and Twitter

Philosys on Facebook and Twitter Philosys released new Facebook and Twitter for sharing Philosys news, product information, healthcare information related to diabetes with our customers. If you would like to know any updates, please visit our Facebook and Twitter page and click like or follow button. Facebook URL: Twitter URL :


   Privacy Policy

HQ & the 1st Factory : +82-63-453-1421
R&D Center : +82-2-553-1421

HQ & the 1st Factory : +82-63-453-1423
R&D Center : +82-2-553-1423

HQ & the 1st Factory : 28-5, Gwangwol-gil, Okgu-eup, Gunsan-si, Jeollabuk-do, Korea, (Postal code: 54172)
R&D Center : 803-2, Innovalley C-dong, 253, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea (Postal Code: 13486)
The 2nd Factory : Pyojun Factory 1-dong 4F, Gunsan FTZ, 15, Jayumuyeok 2-gil, Gunsan-si, Jeollabuk-do, Korea (Postal Code: 54001)